Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $2.52 Billion |
|---|---|
| Enterprise Value | $2.12 Billion |
| Annual dividend | $0.05 |
| Dividend yield | 0.95% |
| Earnings per Share | $-0.04 |
| Beta | 0.29 |
| Outstanding Shares | 480,173,861 |
| P/E Ratio | -75.4 |
|---|---|
| PEG | -72.68 |
| Price to Sales | 5.24 |
| Price to Book Ratio | 1.05 |
| Enterprise Value to Revenue | 2.56 |
| Enterprise Value to EBIT | -114.66 |
| Enterprise Value to Net Income | -62 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, ...